Differentiating Type 1 and Type 2 Myocardial Infarction: Unfortunately, Still More Art Than Science

Marc S Sabatine^{1

2}

Affiliations

¹ Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Deputy Editor, JAMA Cardiology.

Editorial

Marc S Sabatine. JAMA Cardiol. 2021.

. 2021 Jul 1;6(7):781.

doi: 10.1001/jamacardio.2021.0693.

Marc S Sabatine^{1

2}

¹ Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Deputy Editor, JAMA Cardiology.

No abstract available

Comment on

Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
Nestelberger T, Boeddinghaus J, Lopez-Ayala P, Kaier TE, Marber M, Gysin V, Koechlin L, Sanchez AY, Giménez MR, Wussler D, Walter JE, Strebel I, Zimmermann T, Glarner N, Miró Ò, Martin-Sanchez FJ, Zehnder T, Twerenbold R, Keller DI, Mueller C; APACE Investigators. Nestelberger T, et al. JAMA Cardiol. 2021 Jul 1;6(7):771-780. doi: 10.1001/jamacardio.2021.0669. JAMA Cardiol. 2021. PMID: 33881449 Free PMC article.